1. Home
  2. STXS vs NCA Comparison

STXS vs NCA Comparison

Compare STXS & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • NCA
  • Stock Information
  • Founded
  • STXS 1990
  • NCA 1987
  • Country
  • STXS United States
  • NCA United States
  • Employees
  • STXS 139
  • NCA N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NCA Investment Managers
  • Sector
  • STXS Health Care
  • NCA Finance
  • Exchange
  • STXS Nasdaq
  • NCA Nasdaq
  • Market Cap
  • STXS 254.1M
  • NCA 280.8M
  • IPO Year
  • STXS 2004
  • NCA N/A
  • Fundamental
  • Price
  • STXS $2.77
  • NCA $8.71
  • Analyst Decision
  • STXS
  • NCA
  • Analyst Count
  • STXS 0
  • NCA 0
  • Target Price
  • STXS N/A
  • NCA N/A
  • AVG Volume (30 Days)
  • STXS 343.7K
  • NCA 59.6K
  • Earning Date
  • STXS 11-10-2025
  • NCA 01-01-0001
  • Dividend Yield
  • STXS N/A
  • NCA 3.92%
  • EPS Growth
  • STXS N/A
  • NCA N/A
  • EPS
  • STXS N/A
  • NCA N/A
  • Revenue
  • STXS $31,806,000.00
  • NCA N/A
  • Revenue This Year
  • STXS $30.92
  • NCA N/A
  • Revenue Next Year
  • STXS $43.27
  • NCA N/A
  • P/E Ratio
  • STXS N/A
  • NCA N/A
  • Revenue Growth
  • STXS 33.94
  • NCA N/A
  • 52 Week Low
  • STXS $1.54
  • NCA $7.77
  • 52 Week High
  • STXS $3.05
  • NCA $9.12
  • Technical
  • Relative Strength Index (RSI)
  • STXS 51.77
  • NCA 63.45
  • Support Level
  • STXS $2.73
  • NCA $8.51
  • Resistance Level
  • STXS $2.94
  • NCA $8.75
  • Average True Range (ATR)
  • STXS 0.09
  • NCA 0.06
  • MACD
  • STXS -0.03
  • NCA 0.02
  • Stochastic Oscillator
  • STXS 37.07
  • NCA 85.71

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: